J Korean Soc Endocrinol.  2006 Aug;21(4):261-265. 10.3803/jkes.2006.21.4.261.

Regulation of the Expression of a Calcineurin Inhibitor, ZAKI-4alpha

• Cao X
• Kambe F
• Seo H

• KMID: 2200839
• DOI: http://doi.org/10.3803/jkes.2006.21.4.261

Abstract

No abstract available.

MeSH Terms

Calcineurin*
Calcineurin

Figure

• 

  Fig. 1 Thyroid hormone receptor (TR)-mediated non-genomic action of thyroid hormone, activating PI3K and its downstream kinase cascade. PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PI3K, phosphoinositide 3-kinase; PDK1, 3-phosphoinositide-dependent protein kinase 1; mTOR, mammalian target of rapamycine.

Reference

1. Miyazaki T, Kanou Y, Murata Y, Ohmori S, Niwa T, Maeda K, Yamamura H, Seo H. Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem. 1996. 271:14567–14571.

2. Cao X, Kambe F, Miyazaki T, Sarkar D, Ohmori S, Seo H. Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochem J. 2002. 367:459–466.

3. Strippoli P, Lenzi L, Petrini M, Carinci P, Zannotti M. A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). Genomics. 2000. 64:252–263.

4. Kingsbury TJ, Cunningham KW. A conserved family of calcineurin regulators. Genes Dev. 2000. 14:1595–1604.

5. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998. 273:13367–13370.

6. Anthony FA, Winkler MA, Edwards HH, Cheung WY. Quantitative subcellular localization of calmodulin-dependent phosphatase in chick forebrain. J Neurosci. 1988. 8:1245–1253.

7. Fujii H, Hirano T. Calcineurin regulates induction of late phase of cerebellar long-term depression in rat cultured purkinje neurons. Eur J Neurosci. 2002. 16:1777–1788.

8. Takahashi M, Tomizawa K, Ishiguro K. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Brain Res. 2000. 857:193–206.

9. Siddiq A, Miyazaki T, Takagishi Y, Kanou Y, Hayasaka S, Inouye M, Seo H, Murata Y. Expression of ZAKI-4 messenger ribonucleic acid in the brain during rat development and the effect of hypothyroidism. Endocrinology. 2001. 142:1752–1759.

10. Sola C, Tusell JM, Serratosa J. Comparative study of the distribution of calmodulin kinase II and calcineurin in the mouse brain. J Neurosci Res. 1999. 57:651–662.

11. Harvey CB, Williams GR. Mechanism of thyroid hormone action. Thyroid. 2002. 12:441–446.

12. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol. 2005. 19:102–112.

13. Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J. 1998. 333(Pt 3):471–490.

14. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and Ly294002. EMBO J. 1996. 15:5256–5267.

15. Sakaue H, Ogawa W, Takata M, Kuroda S, Kotani K, Matsumoto M, Sakaue M, Nishio S, Ueno H, Kasuga M. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol. 1997. 11:1552–1562.

16. Farese RV. Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med (Maywood). 2001. 226:283–295.

17. Furuya F, Hanover JA, Cheng SY. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci U S A. 2006. 103:1780–1785.

18. Moeller LC, Dumitrescu AM, Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol Endocrinol. 2005. 19:2955–2963.

19. Davis PJ, Tillmann HC, Davis FB, Wehling M. Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones. J Endocrinol Invest. 2002. 25:377–388.

20. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005. 146:2864–2871.

21. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH, Weintraub BD. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest. 1991. 88:2123–2130.

22. Meier CA, Parkison C, Chen A, Ashizawa K, Meier-Heusler SC, Muchmore P, Cheng SY, Weintraub BD. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. J Clin Invest. 1993. 92:1986–1993.

23. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000. 407:538–541.

24. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Cancer Res. 2001. 61:5985–5991.

25. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem. 2003. 278:2118–2123.

26. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem. 2002. 277:25297–25304.